-
公开(公告)号:US06489331B1
公开(公告)日:2002-12-03
申请号:US09719570
申请日:2001-04-09
申请人: Junichi Shimada , Yoshihisa Ohta , Kotaro Takasaki , Miho Suda , Hideaki Kusaka , Hiroshi Yano , Satoshi Nakanishi , Yuzuru Matsuda
发明人: Junichi Shimada , Yoshihisa Ohta , Kotaro Takasaki , Miho Suda , Hideaki Kusaka , Hiroshi Yano , Satoshi Nakanishi , Yuzuru Matsuda
IPC分类号: A61K3152
CPC分类号: C07D487/14 , A61K31/505 , A61K31/519 , Y10S514/866
摘要: A medicament for the therapeutic treatment of diabetes which comprises as an active ingredient a compound represented by the general formula (I): wherein R1 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group, R2 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group, R3 represents a hydrogen atom, a lower alkyl group or a substituted or unsubstituted aralkyl group, X1 and X2 independently represent a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and the symbol “n” represents an integer of from 0 to 3, or a physiologically acceptable salt thereof.
摘要翻译: 一种用于治疗糖尿病的药物,其包含作为活性成分的由通式(I)表示的化合物:其中R 1表示氢原子,低级烷基,取代或未取代的芳基或取代或未取代的芳族 杂环基,R2表示氢原子,低级烷基,取代或未取代的芳烷基,取代或未取代的芳基或取代或未取代的芳香族杂环基,R3表示氢原子,低级烷基或取代 或未取代的芳烷基,X 1和X 2独立地表示氢原子,低级烷基,取代或未取代的芳烷基或取代或未取代的芳基,符号“n”表示0〜3的整数,或 其生理上可接受的盐。
-
公开(公告)号:US07005430B2
公开(公告)日:2006-02-28
申请号:US10149423
申请日:2000-12-22
申请人: Kimihisa Ueno , Akira Ogawa , Yoshihisa Ohta , Yuji Nomoto , Kotaro Takasaki , Hideaki Kusaka , Hiroshi Yano , Chiharu Nakagawa , Satoshi Nakanishi
发明人: Kimihisa Ueno , Akira Ogawa , Yoshihisa Ohta , Yuji Nomoto , Kotaro Takasaki , Hideaki Kusaka , Hiroshi Yano , Chiharu Nakagawa , Satoshi Nakanishi
IPC分类号: C07D487/14 , C07D473/24 , C07D473/22 , A61K31/519 , A61P3/10
CPC分类号: C07D487/14
摘要: A condensed purine derivative represented by Formula (I): wherein X—Y-Z represents R1N—C═O or N═C—W, R2 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted alicyclic heterocyclic group or the like, n represents an integer of from 0 to 3, V1 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group, V2 represents a substituted lower alkyl group or a substituted or unsubstituted aromatic heterocyclic group, and when V1 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and for example, X—Y-Z represents R1aN—C═O and R2 represents a substituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted alicyclic heterocyclic group, a halogen atom, a lower alkylthio group, —NR7R8, —CO2H, a lower alkoxycarbonyl group, —COHal, —CONR9R10 or —CHO, V2 may represent a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; or a pharmacologically acceptable salt thereof.
摘要翻译: 由式(I)表示的稠合嘌呤衍生物:化学式id =“CHEM-US-00001”num =“000”
-
公开(公告)号:US20060252780A1
公开(公告)日:2006-11-09
申请号:US10554254
申请日:2004-04-23
申请人: Takao Nakajima , Kimihisa Ueno , Yuji Nomoto , Yuichi Matsumoto , Hiroshi Yano , Satoshi Nakanishi , Kotaro Takasaki , Hideaki Kusaka
发明人: Takao Nakajima , Kimihisa Ueno , Yuji Nomoto , Yuichi Matsumoto , Hiroshi Yano , Satoshi Nakanishi , Kotaro Takasaki , Hideaki Kusaka
IPC分类号: A61K31/519 , C07D487/14
CPC分类号: C07D487/14
摘要: A fused pyrimidine derivative is presented. The derivatie has an insulin secretion stimulating activity represented by Formula (I): {wherein R1 represents a hydrogen atom, lower alkyl, or the like; n represents an integer of 0 to 3; and X1 and X2 may be the same or different and each represents a hydrogen atom, lower alkyl, or the like; and formula (II): represents formula (III): [wherein X—Y—Z represents R2C═CR3—NR4 (wherein R2, R3 and R4 may be the same or different and each represents a hydrogen atom, lower alkyl, or the like)]}, or a pharmaceutically acceptable salt thereof.
摘要翻译: 提出了一种稠合的嘧啶衍生物。 衍生物具有由式(I)表示的胰岛素分泌刺激活性:其中R 1表示氢原子,低级烷基等; n表示0〜3的整数, X 1和X 2可以相同或不同,各自表示氢原子,低级烷基等; 和式(II):表示式(III):[其中XYZ表示R 2 C-CR 3 -NR 4(其中R' O 2,R 3和R 4可以相同或不同,各自表示氢原子,低级烷基等)]}, 或其药学上可接受的盐。
-
公开(公告)号:US20060046992A1
公开(公告)日:2006-03-02
申请号:US10519630
申请日:2003-06-25
申请人: Daisuke Machii , Koji Suzuki , Tsutomu Matsumura , Hitoshi Arai , Miho Iwase , Hiroshi Yano , Satoshi Nakanishi , Fumiko Ogino , Kotaro Takasaki , Hideaki Kusaka
发明人: Daisuke Machii , Koji Suzuki , Tsutomu Matsumura , Hitoshi Arai , Miho Iwase , Hiroshi Yano , Satoshi Nakanishi , Fumiko Ogino , Kotaro Takasaki , Hideaki Kusaka
IPC分类号: A61K31/519 , C07D487/04
CPC分类号: C07D471/04 , A61K31/437 , A61K31/445 , A61K31/4453 , A61K31/4545 , A61K31/496 , A61K31/519 , A61K31/5377 , A61K31/55 , C07D487/04
摘要: The present invention provides a compound represented by formula (I): [wherein X—Y-Z represents R5N—C═O (wherein R5 represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted lower alkenyl, or substituted or unsubstituted lower alkynyl), etc; R1 and R2 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc; and R3 and R4 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc], or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供由式(I)表示的化合物:[其中XYZ表示R 5 NCO(其中R 5表示氢原子,取代或未取代的低级烷基,取代的 或未取代的芳烷基,取代或未取代的低级烯基,或取代或未取代的低级炔基)等; R 1和R 2可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等; R 3和R 4可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等]或其药学上可接受的盐。
-
-
-